SCHEMBL19081112

SCHEMBL19081112

CC1(C)c2c(ccc3ccccc23)-c2ccc3c(sc4cc(-c5c6ccccc6c(-c6ccc(-c7ccccc7)cc6)c6ccccc56)ccc43)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
MCL1 Q07820 2/20 0.35
LIMK1 P53667 2/20 0.34
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 2/20 0.32
F9 P00740 3/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
SOS1 Q07889 1/20 0.30
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
APEX1 P27695 1/20 0.30
HTT P42858 1/20 0.30
RECQL P46063 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
ABCB1 P08183 1/20 0.30
MAPK9 P45984 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081110 0.88 CYP1A1 (0.34) CYP1A1CYP1B1MCL1LIMK1ALOX5
SCHEMBL19081109 0.87 CYP1A1 (0.35) CYP1A1CYP1B1MCL1LIMK1CYP1A2
SCHEMBL19081146 0.86 LIMK1 (0.33) CYP1A1CYP1B1MCL1LIMK1ALOX5
SCHEMBL19081144 0.84 F9 (0.33) CYP1A1CYP1B1MCL1LIMK1ALOX5
SCHEMBL19081240 0.84 F9 (0.32) CYP1A1CYP1B1LIMK1ALOX5CYP1A2
SCHEMBL17944921 0.83 CYP1A1 (0.38) CYP1A1CYP1B1MCL1LIMK1ALOX5
SCHEMBL19081064 0.83 ALOX5 (0.35) CYP1A1CYP1B1MCL1ALOX5CYP1A2
SCHEMBL17247184 0.83 CYP1A1 (0.48) CYP1A1CYP1B1MCL1LIMK1ALOX5
SCHEMBL19081209 0.83 ALOX5 (0.33) CYP1A1CYP1B1ALOX5F9SOS1
SCHEMBL19081142 0.83 F9 (0.36) CYP1A1CYP1B1MCL1LIMK1F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885MCL1 1139/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885MCL1 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.